Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Lupus, a Leading Cause of Years of Potential Life Lost in Young Women: Implications for Public Health Priorities and Research Funding.
Journal: ACR open rheumatology
Published: February 04, 2026
Steady decrease in systemic sclerosis mortality rates at younger ages over the past five decades.
Journal: Rheumatology (Oxford, England)
Published: August 25, 2022
Worsening premature death burden gap from systemic sclerosis in men and black persons: A US nationwide population-based study.
Journal: Journal of scleroderma and related disorders
Published: August 10, 2022
Consensus Treatment Plans for Severe Pediatric Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Journal: Arthritis care & research
Published: October 19, 2020
Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968-2015: A US Population-Based Study.
Journal: Arthritis care & research
Published: September 11, 2019
SLE mortality remains disproportionately high, despite improvements over the last decade.
Journal: Lupus
Published: July 19, 2018
Brief Report: Lupus-An Unrecognized Leading Cause of Death in Young Females: A Population-Based Study Using Nationwide Death Certificates, 2000-2015.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 09, 2018
46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013: A Nationwide Population-Based Study.
Journal: Annals of internal medicine
Published: November 01, 2017
Approach to Membranous Lupus Nephritis: A Survey of Pediatric Nephrologists and Pediatric Rheumatologists.
Journal: The Journal of rheumatology
Published: July 14, 2017
Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.
Journal: Pediatric rheumatology online journal
Published: April 10, 2017
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.
Journal: Alimentary pharmacology & therapeutics
Published: March 08, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026